|
|
|
Technology |
| |
|
| |
 |
|
Promogen’s patented platform technology involves innovations
in recombinant gene expression. This state-of-art technology
enables high throughput production of synthetic gene promoters.The
best performing promoters are selected from tens of millions
of potential candidates. These promoters are capable of expressing
genes with either ultra high selectivity and efficiency (Targeting
Promoters) or dramatically enhanced activity (Super Promoters).
Ultimately, the technology will be leveraged for the development
of gene therapy drugs for the treatment of cancers and diseases.
Potential Application of-Promogen’s Technology:
Promogen’s vector applied to lung tumor specific gene therapy.
As shown in the diagram, using Promogen’s vector system in gene
therapy would allow elimination of the tumor without creating
any harmful effects in normal tissues.
|
| |
|
|
Targeting Promoters: Gene
Therapy |
| |
|
|
| |
 |
| |
|
|
Super Promoters: Recomb. Protein Manufacturing
|
| |
| |
 |
| |
|
